EMA and US FDA to accept single orphan drug designation annual report
This article was originally published in Scrip
Executive Summary
Sponsors of orphan drugs and biologics now have the option of submitting a single annual report to the European Medicines Agency and the US Food and Drug Administration for products designated in both jurisdictions.